Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Interest & Investment Income (2017 - 2025)

Lipocine (LPCN) has disclosed Interest & Investment Income for 9 consecutive years, with $174208.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest & Investment Income fell 36.32% year-over-year to $174208.0, compared with a TTM value of $831475.0 through Sep 2025, down 31.46%, and an annual FY2024 reading of $1.1 million, down 16.1% over the prior year.
  • Interest & Investment Income was $174208.0 for Q3 2025 at Lipocine, down from $198638.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $379522.0 in Q2 2023 and bottomed at $10649.0 in Q1 2021.
  • Average Interest & Investment Income over 5 years is $197498.8, with a median of $225511.0 recorded in 2025.
  • The sharpest move saw Interest & Investment Income tumbled 82.23% in 2021, then soared 1224.06% in 2022.
  • Year by year, Interest & Investment Income stood at $22443.0 in 2021, then skyrocketed by 1224.06% to $297158.0 in 2022, then rose by 0.75% to $299379.0 in 2023, then dropped by 22.13% to $233118.0 in 2024, then decreased by 25.27% to $174208.0 in 2025.
  • Business Quant data shows Interest & Investment Income for LPCN at $174208.0 in Q3 2025, $198638.0 in Q2 2025, and $225511.0 in Q1 2025.